Atea Pharmaceuticals Inc (AVIR)
Stock chart
Loading...
•
Purchase
•
Sale
•
Planned purchase
•
Planned sale
Net purchase
Net sale
Earnings
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2024-12-12 | 2024-12-10 | S Sale | Non-Executive Director |
359,606
-44.3%
2.85USD 1,023,475 |
359,606 -44.3% | 2.85 | USD 1,023,475 | |
| 2024-09-19 | 2024-09-19 | S Sale |
President, CEO, and Chairman Executive Director |
1,841
-0.0%
4.00USD 7,367 |
1,841 -0.0% | 4.00 | USD 7,367 | |
| 2024-09-19 | 2024-09-18 | S Sale |
President, CEO, and Chairman Executive Director |
22,187
-0.4%
4.03USD 89,469 |
22,187 -0.4% | 4.03 | USD 89,469 | |
| 2024-09-19 | 2024-09-17 | S Sale |
President, CEO, and Chairman Executive Director |
33,941
-0.6%
4.05USD 137,318 |
33,941 -0.6% | 4.05 | USD 137,318 | |
| 2024-06-21 | 2024-06-20 | S Sale | Non-Executive Director |
17,544
-21.1%
3.49USD 61,144 |
17,544 -21.1% | 3.49 | USD 61,144 | |
| 2024-06-07 | 2024-06-05 | S Sale |
President, CEO, and Chairman Executive Director |
1,006
-0.0%
4.00USD 4,024 |
1,006 -0.0% | 4.00 | USD 4,024 | |
| 2024-02-02 | 2024-02-01 | PS Planned sale |
Chief Development Officer Officer |
14,029
-28.4%
3.84USD 53,913 |
14,029 -28.4% | 3.84 | USD 53,913 | |
| 2024-02-02 | 2024-02-01 | PS Planned sale |
Chief Medical Officer Officer |
15,870
-38.2%
3.84USD 60,963 |
15,870 -38.2% | 3.84 | USD 60,963 | |
| 2024-02-02 | 2024-02-01 | PS Planned sale |
EVP, Chief Accounting Officer Officer |
12,477
-37.4%
3.84USD 47,904 |
12,477 -37.4% | 3.84 | USD 47,904 | |
| 2024-02-02 | 2024-02-01 | PS Planned sale |
President, CEO, and Chairman Executive Director |
56,910
-32.8%
3.85USD 218,819 |
56,910 -32.8% | 3.85 | USD 218,819 | |
| 2024-02-02 | 2024-02-01 | PS Planned sale |
See Remarks Officer |
15,843
-2.3%
3.84USD 60,915 |
15,843 -2.3% | 3.84 | USD 60,915 | |
| 2024-02-02 | 2024-02-01 | PS Planned sale |
Chief Commercial Officer Officer |
11,819
-35.5%
3.84USD 45,420 |
11,819 -35.5% | 3.84 | USD 45,420 | |
| 2022-11-15 | 2022-11-14 | S Sale | Non-Executive Director |
16,166
-2.0%
5.16USD 83,352 |
16,166 -2.0% | 5.16 | USD 83,352 | |
| 2022-11-15 | 2022-11-11 | S Sale | Non-Executive Director |
25,500
-3.1%
5.15USD 131,333 |
25,500 -3.1% | 5.15 | USD 131,333 | |
| 2021-12-21 | 2021-12-20 | B Purchase | Non-Executive Director |
12,000
+106.2%
8.57USD 102,796 |
12,000 +106.2% | 8.57 | USD 102,796 | |
| 2020-11-04 | 2020-11-03 | B Purchase |
Rock Springs Capital Management LP Large shareholder |
7,292
+2.6%
24.00USD 175,008 |
7,292 +2.6% | 24.00 | USD 175,008 | |
| 2020-11-04 | 2020-11-03 | B Purchase |
Rock Springs Capital Management LP Large shareholder |
242,708
+17.2%
24.00USD 5,824,992 |
242,708 +17.2% | 24.00 | USD 5,824,992 | |
| 2020-11-03 | 2020-11-03 | B Purchase | Non-Executive Director |
41,666
+5.4%
24.00USD 999,984 |
41,666 +5.4% | 24.00 | USD 999,984 | |
| 2020-11-03 | 2020-11-03 | B Purchase | Non-Executive Director |
250,000
+4.7%
24.00USD 6,000,000 |
250,000 +4.7% | 24.00 | USD 6,000,000 |